Graham R. Christie
University of Dundee
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Graham R. Christie.
Journal of Biological Chemistry | 2002
Graham R. Christie; Eric Hajduch; Harinder S. Hundal; Christopher G. Proud; Peter M. Taylor
Amino acids exert modulatory effects on proteins involved in control of mRNA translation in animal cells through the target of rapamycin (TOR) signaling pathway. Here we use oocytes ofXenopus laevis to investigate mechanisms by which amino acids are “sensed” in animal cells. Small (∼48%) but physiologically relevant increases in intracellular but not extracellular total amino acid concentration (or Leu or Trp but not Ala, Glu, or Gln alone) resulted in increased phosphorylation of p70S6K and its substrate ribosomal protein S6. This response was inhibited by rapamycin, demonstrating that the effects require the TOR pathway. Alcohols of active amino acids substituted for amino acids with lower efficiency. Oocytes were refractory to changes in external amino acid concentration unless surface permeability of the cell to amino acids was increased by overexpression of the System L amino acid transporter. Amino acid-induced, rapamycin-sensitive activation of p70S6K was conferred when System L-expressing oocytes were incubated in extracellular amino acids, supporting intracellular localization of the putative amino acid sensor. In contrast to lower eukaryotes such as yeast, which possess an extracellular amino acid sensor, our findings provide the first direct evidence for an intracellular location for the putative amino acid sensor in animal cells that signals increased amino acid availability to TOR/p70S6K.
Journal of Biological Chemistry | 2007
Ruth A. Valentine; Kelly A. Jackson; Graham R. Christie; John C. Mathers; Peter M. Taylor; Dianne Ford
Zinc is an essential micronutrient, so it is important to elucidate the molecular mechanisms of zinc homeostasis, including the functional properties of zinc transporters. Mammalian zinc transporters are classified in two major families: the SLC30 (ZnT) family and the SLC39 family. The prevailing view is that SLC30 family transporters function to reduce cytosolic zinc concentration, either through efflux across the plasma membrane or through sequestration in intracellular compartments, and that SLC39 family transporters function in the opposite direction to increase cytosolic zinc concentration. We demonstrated that human ZnT5 variant B (ZnT5B (hZTL1)), an isoform expressed at the plasma membrane, operates in both the uptake and the efflux directions when expressed in Xenopus laevis oocytes. We measured increased activity of the zinc-responsive metallothionein 2a (MT2a) promoter when ZnT5b was co-expressed with an MT2a promoter-reporter plasmid construct in human intestinal Caco-2 cells, indicating increased total intracellular zinc concentration. Increased cytoplasmic zinc concentration mediated by ZnT5B, in the absence of effects on intracellular zinc sequestration by the Golgi apparatus or endoplasmic reticulum, was also confirmed by a dramatically enhanced signal from the zinc fluorophore Rhodzin-3 throughout the cytoplasm of Caco-2 cells overexpressing ZnT5B at the plasma membrane when compared with control cells. Our findings demonstrate clearly that, in addition to mediating zinc efflux, ZnT5B at the plasma membrane can function to increase cytoplasmic zinc concentration, thus indicating a need to reevaluate the current paradigm that SLC30 family zinc transporters operate exclusively to decrease cytosolic zinc concentration.
Molecular and Cellular Biology | 2005
Graham R. Christie; David J. Williams; Fiona MacIsaac; Robin J. Dickinson; Ian Rosewell; Stephen M. Keyse
ABSTRACT To elucidate the physiological role(s) of DUSP9 (dual-specificity phosphatase 9), also known as MKP-4 (mitogen-activated protein kinase [MAPK] phosphatase 4), the gene was deleted in mice. Crossing male chimeras with wild-type females resulted in heterozygous (DUSP9+/−) females. However, when these animals were crossed with wild-type (DUSP9+/y) males none of the progeny carried the targeted DUSP9 allele, indicating that both female heterozygous and male null (DUSP9−/y) animals die in utero. The DUSP9 gene is on the X chromosome, and this pattern of embryonic lethality is consistent with the selective inactivation of the paternal X chromosome in the extraembryonic tissues of the mouse, suggesting that DUSP9/MKP4 performs an essential function during placental development. Examination of embryos between 8 and 10.5 days postcoitum confirmed that lethality was due to a failure of labyrinth development, and this correlates exactly with the normal expression pattern of DUSP9/MKP-4 in the trophoblast giant cells and labyrinth of the placenta. Finally, when the placental defect was rescued, male null (DUSP9−/y) embryos developed to term, appeared normal, and were fertile. Our results indicate that DUSP9/MKP-4 is essential for placental organogenesis but is otherwise dispensable for mammalian embryonic development and highlights the critical role of dual-specificity MAPK phosphatases in the regulation of developmental outcomes in vertebrates.
Cellular Physiology and Biochemistry | 2001
James Ritchie; Fiona E. Baird; Graham R. Christie; Alison Stewart; Sylvia Y. Low; Harinder S. Hundal; Peter M. Taylor
Adipose tissue is a major site for whole-body glutamine synthesis and we are investigating mechanisms and regulation of glutamine transport across the adipocyte membrane. Glutamine transport in adipocytes includes both high- and low-affinity Na+-dependent components (consistent with observed expression of ASCT2 and ATA2/SAT2 transporter mRNAs respectively) and a Na+-independent transport component (consistent with observed expression of LAT1/2 transporter mRNAs). Hypo-osmotic (235 mosmol/kg) swelling of adipocytes transiently stimulated glutamine uptake (180% increase at 0.05 mM glutamine) within 5 mins. Stimulation was blocked by the tyrosine kinase inhibitor genistein and the MAP kinase pathway inhibitors PD98059 and SB203580, but not by wortmannin (PI 3-kinase inhibitor) or rapamycin (mTOR pathway inhibitor). Cell-swelling also stimulated uptake of glucose but not MeAIB (indicating that ASCT2 rather than ATA2 was stimulated by swelling). Insulin (66 nM) treatment for up to 1 h stimulated Na+-dependent glutamine transport and increased adipocyte water space. Activation of the ERK1-2 MAP kinase pathway by cell swelling or insulin may be important for rapid activation of the ASCT2 glutamine transporter in adipocytes. Insulin may also exert a minor additional stimulatory effect on adipocyte glutamine transport indirectly via cell swelling. The mechanisms regulating glutamine transport in adipose tissue are distinct from those in other major sites of glutamine turnover in the body (notably liver and skeletal muscle).
Current Opinion in Clinical Nutrition and Metabolic Care | 2001
Graham R. Christie; Russell Hyde; Harinder S. Hundal
There is growing recognition that amino acid availability has profound effects on many aspects of cell function, including the control of membrane transport mechanisms, cell signalling, and gene expression. The precise mechanisms by which amino acids are able to elicit control over such diverse processes have become the focus of intense investigation recently. One particular area that has seen considerable advances is the molecular characterization of amino acid transporters, including members of the System A family, which are known to be regulated by amino acid supply. Recent developments concerning how cells sense and signal amino acid availability, and how this process influences the expression and function of amino acid transporters, are reviewed here. Elucidating the molecular mechanisms of these events will be important in clarifying how amino acid transporters might be regulated during altered nutritional states, and will be crucial for the design of new strategies aimed at improving nutritional support.
Biochemical Journal | 2001
Russell Hyde; Graham R. Christie; Gary J. Litherland; Eric Hajduch; Peter M. Taylor; Harinder S. Hundal
Molecular Endocrinology | 2003
James Ritchie; Yun-Bo Shi; Yoshitaka Hayashi; Fiona E. Baird; R. W. Muchekehu; Graham R. Christie; Peter M. Taylor
FEBS Journal | 1997
Helen E. Mcdowell; Trevor Walker; Eric Hajduch; Graham R. Christie; Ian H. Batty; C. Peter Downes; Harinder S. Hundal
Gastroenterology | 2001
Graham R. Christie; Dianne Ford; Alison Howard; M. Ann Clark; Barry H. Hirst
American Journal of Physiology-cell Physiology | 1995
Helen E. Mcdowell; Graham R. Christie; G. Stenhouse; Harinder S. Hundal